TCF7L2 and type 2 diabetes mellitus: TCF7L2 mRNA expression is reported to be the strongest type-2 diabetes candidate gene and inactivation of TCF7L2 leads to hepatic insulin resistance and decreased whole body glucose tolerance (43).